Aripiprazole combination for reversal of paliperidone-induced increase in prolactin level
Pu Zhi,1,* Yanqiong Wang,1,* Wei Quan,1,2 Yanli Su,1 Hui Zhang1 1Department of Psychiatry, Xi’an Mental Health Center, Institute of Mental Health, Xi’an Medical University, Xi’an, China; 2Department of Natural Medicine, Institute of Materia Medica, School of Pharmacy,...
Guardado en:
Autores principales: | , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/3a8334b505024f8890df9b6842727cdd |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:3a8334b505024f8890df9b6842727cdd |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:3a8334b505024f8890df9b6842727cdd2021-12-02T03:48:29ZAripiprazole combination for reversal of paliperidone-induced increase in prolactin level1178-2021https://doaj.org/article/3a8334b505024f8890df9b6842727cdd2018-08-01T00:00:00Zhttps://www.dovepress.com/aripiprazole-combination-for-reversal-of-paliperidone-induced-increase-peer-reviewed-article-NDThttps://doaj.org/toc/1178-2021Pu Zhi,1,* Yanqiong Wang,1,* Wei Quan,1,2 Yanli Su,1 Hui Zhang1 1Department of Psychiatry, Xi’an Mental Health Center, Institute of Mental Health, Xi’an Medical University, Xi’an, China; 2Department of Natural Medicine, Institute of Materia Medica, School of Pharmacy, Fourth Military Medical University, Xi’an, China *These authors contributed equally to this work Abstract: Hyperprolactinemia is a common side effect of antipsychotic drugs. Although changes of antipsychotic drugs or reduction of their doses can solve this problem, a modification of the treatment regimen can lead to instability in patients. Herein, we followed up a patient with elevated prolactin caused by paliperidone and found that the prolactin level was decreased after the administration of a combination with a low-dose aripiprazole. In addition, we summarized and analyzed the findings from the case and the literature review conducted. Keywords: aripiprazole, schizophrenia, prolactinZhi PWang YQuan WSu YZhang HDove Medical PressarticlearipiprazoleschizophreniaprolactinNeurosciences. Biological psychiatry. NeuropsychiatryRC321-571Neurology. Diseases of the nervous systemRC346-429ENNeuropsychiatric Disease and Treatment, Vol Volume 14, Pp 2175-2179 (2018) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
aripiprazole schizophrenia prolactin Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429 |
spellingShingle |
aripiprazole schizophrenia prolactin Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429 Zhi P Wang Y Quan W Su Y Zhang H Aripiprazole combination for reversal of paliperidone-induced increase in prolactin level |
description |
Pu Zhi,1,* Yanqiong Wang,1,* Wei Quan,1,2 Yanli Su,1 Hui Zhang1 1Department of Psychiatry, Xi’an Mental Health Center, Institute of Mental Health, Xi’an Medical University, Xi’an, China; 2Department of Natural Medicine, Institute of Materia Medica, School of Pharmacy, Fourth Military Medical University, Xi’an, China *These authors contributed equally to this work Abstract: Hyperprolactinemia is a common side effect of antipsychotic drugs. Although changes of antipsychotic drugs or reduction of their doses can solve this problem, a modification of the treatment regimen can lead to instability in patients. Herein, we followed up a patient with elevated prolactin caused by paliperidone and found that the prolactin level was decreased after the administration of a combination with a low-dose aripiprazole. In addition, we summarized and analyzed the findings from the case and the literature review conducted. Keywords: aripiprazole, schizophrenia, prolactin |
format |
article |
author |
Zhi P Wang Y Quan W Su Y Zhang H |
author_facet |
Zhi P Wang Y Quan W Su Y Zhang H |
author_sort |
Zhi P |
title |
Aripiprazole combination for reversal of paliperidone-induced increase in prolactin level |
title_short |
Aripiprazole combination for reversal of paliperidone-induced increase in prolactin level |
title_full |
Aripiprazole combination for reversal of paliperidone-induced increase in prolactin level |
title_fullStr |
Aripiprazole combination for reversal of paliperidone-induced increase in prolactin level |
title_full_unstemmed |
Aripiprazole combination for reversal of paliperidone-induced increase in prolactin level |
title_sort |
aripiprazole combination for reversal of paliperidone-induced increase in prolactin level |
publisher |
Dove Medical Press |
publishDate |
2018 |
url |
https://doaj.org/article/3a8334b505024f8890df9b6842727cdd |
work_keys_str_mv |
AT zhip aripiprazolecombinationforreversalofpaliperidoneinducedincreaseinprolactinlevel AT wangy aripiprazolecombinationforreversalofpaliperidoneinducedincreaseinprolactinlevel AT quanw aripiprazolecombinationforreversalofpaliperidoneinducedincreaseinprolactinlevel AT suy aripiprazolecombinationforreversalofpaliperidoneinducedincreaseinprolactinlevel AT zhangh aripiprazolecombinationforreversalofpaliperidoneinducedincreaseinprolactinlevel |
_version_ |
1718401597123330048 |